Division of General Surgery

Medicine & Life Sciences

1. Meta-Analysis 100%
2. Randomized Controlled Trials 64%
3. Systematic Reviews 51%
4. Breast Neoplasms 44%
5. Neoplasms 37%
6. Hepatocellular Carcinoma 33%
7. glucose-regulated proteins 29%
8. Confidence Intervals 28%
9. Colorectal Neoplasms 28%
10. Neoplasm Metastasis 27%
11. Taiwan 24%
12. Rectal Neoplasms 23%
13. Nicotinic Receptors 21%
14. Colonic Neoplasms 21%
15. Cell Movement 19%
16. Therapeutics 19%
17. Nicotine 16%
18. pterostilbene 16%
19. Robotics 15%
20. Laparoscopy 13%
21. Odds Ratio 13%
22. Liver 13%
23. PubMed 13%
24. Incidence 13%
25. MicroRNAs 12%
26. Gastrectomy 12%
27. Apoptosis 12%
28. Down-Regulation 12%
29. Curcumin 12%
30. Stomach Neoplasms 11%
31. Breast 11%
32. Neoplastic Stem Cells 11%
33. Libraries 11%
34. Survival 11%
35. Carcinogenesis 11%
36. Bariatric Surgery 10%
37. Epithelial-Mesenchymal Transition 10%
38. Databases 10%
39. Pain 10%
40. Population 10%
41. Safety 10%
42. Triple Negative Breast Neoplasms 10%
43. Gastric Bypass 10%
44. Lung Neoplasms 9%
45. Autophagy 9%
46. Recurrence 9%
47. Stomach 9%
48. Antrodia 9%
49. Weight Loss 9%
50. Length of Stay 8%
51. Quality of Life 8%
52. Drug Therapy 8%
53. Thrombomodulin 8%
54. Serum 8%
55. Cohort Studies 8%
56. Morbid Obesity 8%
57. Appendectomy 8%
58. Shared Decision Making 8%
59. Smoking 8%
60. Colon 8%
61. Advanced Glycation End Products 7%
62. Macrophages 7%
63. Learning Curve 7%
64. Carcinoma 7%
65. Lung 7%
66. Growth 7%
67. Up-Regulation 7%
68. Fluorouracil 7%
69. Mortality 7%
70. Herniorrhaphy 7%
71. Thyroid Neoplasms 7%
72. Prostatic Neoplasms 7%
73. gemcitabine 7%
74. Gene Expression 7%
75. Transanal Endoscopic Surgery 6%
76. Survivin 6%
77. Proteins 6%
78. Genes 6%
79. Small Interfering RNA 6%
80. Intussusception 6%
81. Catenins 6%
82. Sorafenib 6%
83. In Vitro Techniques 6%
84. SERPIN-B5 6%
85. Body Mass Index 6%
86. antrocin 6%
87. Hemorrhage 6%
88. Postoperative Pain 6%
89. Resveratrol 6%
90. Hormones 6%
91. Retrospective Studies 6%
92. Phloretin 6%
93. p38 Mitogen-Activated Protein Kinases 6%
94. Wounds and Injuries 5%
95. ErbB Receptors 5%
96. Paclitaxel 5%
97. Hydrogen Peroxide 5%
98. Lymph Nodes 5%
99. Cell Line 5%
100. Survival Rate 5%